BioPharmaTrend
Latest News
All Topics
  • Artificial Intelligence
  • NeuroTech
  • Premium Content
  • Knowledge Center
Interviews
Companies
  • Company Directory
  • Sponsored Case Studies
  • Create Company Profile
More
  • About Us
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Subscribe
Login/Join

  Artificial Intelligence

ConstruQt – The Beginnings of the Chemical Data Revolution

by Peter Jarowski  (contributor )   •   Feb. 4, 2020  

Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com.
Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy.

# AI & Digital   
Share:   Share in LinkedIn  Share in Bluesky  Share in Reddit  Share in Hacker News  Share in X  Share in Facebook  Send by email

Chemical Data Has Problems

The state of data access, quality and dissemination in Chemistry is extremely poor - so poor that it is blocking advances in machine learning (ML) and artificial intelligence (AI), and also impeding research and development in traditional methods. The recent surge in AI skepticism is a direct consequence of years of over-hype and promises based on precarious data. Over-the-top expectation were offered without enough consideration for the data quality and volume required to train fancy algorithms. The old adage “^&$% in, ^&$% out” holds true (we can say ‘crap’ right?). This opinion is in line with recent statements by the CEO of Novartis, for example, who runs the second largest pharmaceutical company in the world, lamenting the difficulty in accessing quality datasets to make AI effective.

#advertisement
AI in Drug Discovery Report 2025

ChemAlive is building a platform to solve this problem by offering advanced computational tools in exchange for academic raw and live chemical data. ConstruQt is our first freemium web application module showing how this interaction works. It provides quantum mechanical molecular energetic and structural analysis designed for library scale (big data) research and simply asks that researchers deposit their chemical structures upon submission.

Chemical Data is Damn Valuable

Let’s set the context. “Data is the new gold” is a statement of increasing significance. Scientific data as an industry is at least 20 billion USD p.a. based on the size of the peer reviewed scientific publication market. About 5 billion of that is related to Chemistry. In fact, chemical data is the most valuable scientific data based on highest frequency of journal article piracy – in other words, it is data (recipes) worth stealing. Chemistry and Electronic Engineering (EE) account together for over 50% of all patents filed. The monetary value of patents in Chemistry, based on patent sale price, far exceeds EE. Companies distributing published chemical data like Scifinder, Reaxys are only aggregators of the hard-earned, high-value data of, mostly, academic researchers, but they also act as gatekeepers to organized chemical information, with quite an upside for themselves. Public initiatives like Pubchem and Chemspider do not have the same pizazz as their business counterparts, but are widely used to retrieve basic chemical information. Government initiatives like NIST can be important tools as well. However, there is a problem. None of these platforms (commercial or public) are built for big data analytics. Their business models or data architectures do not allow a non-sparse connection between large curated datasets of molecular properties connected directly to molecular structure freely searchable.

A Walk through the Chemical Data Freak Show

Continue reading

This content available exclusively for BPT Mebmers

 BPT Membership 

Topics: AI & Digital   

Share:   Share in LinkedIn  Share in Bluesky  Share in Reddit  Share in Hacker News  Share in X  Share in Facebook  Send by email
#advertisement
ThermoFisher Scientific: Integrated genetic technologies for cell therapy development
#advertisement
Webinar: AI in Clinical Trials

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
gnews  Google News
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Premium Content
  • BioTech Scout
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Membership
  • Advertise
  • Submit Company
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.